尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Ginn Richard. Director active across 1 company, notably Tenon Medical, Inc.. Cumulatively, 4 disclosures have been logged. Activity tracked since 22 May 2023. The latest transaction was disclosed on 31 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
GINN RICHARD is a declarant linked to Tenon Medical, Inc., where he holds the role of Chief Technology Officer. He has 4 filings in total, and the sampled recent filings cover the period from 2023-05-24 to 2026-08-04, with the transaction nature listed as option exercise.